authors
- Smolderen, Kim G
- Knop, Filip K
- Michael Nanna, MD, MHS
- Mena-Hurtado, Carlos
- Divino, Victoria
- Zhao, Zhenxiang
- Chen, Yan
- Boland, Joanna
- Chao, Ariel
- Song, Jinlin
- Smolarz, B Gabriel
Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: The SCORE - primary prevention study.
- Overview
- Research
- Identity
- Additional Document Info
- View All